Marizyme, Inc. MRZM
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0081 Day range 0.0081
0.0003 52-week range 0.0081
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 39.54K
- EPS (ttm)
- -0.27
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 1.97K
- Open
- 0.0081
- Previous close
- 0.0003
- Day's range
- 0.0081 – 0.0081
- 52-week range
- 0.0003 – 0.0081
3M 0.0000 (0.00%)
News
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ 
Marizyme CEO Delivers Business Update 
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™ 
U.S. IPO Weekly Recap: The IPO Market's Micro-Cap Run Continues With 2 Small Healthcare Deals 
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO 
Marizyme, Inc. Issues Letter to Shareholders 
Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera 
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems 
Marizyme Announces Approval for DuraGraft® in India 
Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
Your note
Sign in to keep a note on MRZM — it syncs with the Stock Master app.